RadNet, Inc. Accounts Payable
RadNet, Inc. (RDNT) had Accounts Payable of $153.23 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-03-02
- 2025-12-31: Accounts Payable, Current $153.23M.
- 2024-12-31: Accounts Payable, Current $96.45M.
- 2023-12-31: Accounts Payable, Current $122.89M.
- 2022-12-31: Accounts Payable, Current $102.68M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-12-31 | $153.23M 10-K · filed 2026-03-02 | |
| 2024-12-31 | $96.45M 10-K · filed 2026-03-02 | |
| 2023-12-31 | $122.89M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $102.68M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $86.46M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $70.07M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $64.30M 10-K · filed 2021-03-16 | |
| 2018-12-31 | $68.04M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $28.54M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $40.95M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $1.00K 10-K/A · filed 2017-03-31 | $52.30M 10-K · filed 2016-03-15 |
| 2014-12-31 | $98.00K 10-K/A · filed 2016-03-30 | $46.85M 10-K · filed 2015-03-16 |
| 2013-12-31 | $658.00K 10-K · filed 2015-03-31 | $36.96M 10-K · filed 2014-03-17 |
| 2012-12-31 | $839.00K 10-K/A · filed 2014-03-31 | $39.18M 10-K · filed 2013-03-18 |
| 2011-12-31 | $873.00K 10-K/A · filed 2013-11-13 | $29.98M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |